Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy SubjectsCompleted
NCT05526690Phase 1Updated Aug 14, 2023
Sponsor: AstraZeneca
Hypertension
United States
Baxdrostat Bioavailability and Bioequivalence StudyCompleted
NCT05963009Phase 1Updated Aug 14, 2023
Sponsor: AstraZeneca
Hypertension
United States
Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung CancerCompleted
NCT04742192N/AUpdated Aug 14, 2023
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
Argentina, Chile, Colombia, Costa Rica, Dominican Republic +10 more
Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal FunctionCompleted
NCT05470725Phase 1Updated Aug 14, 2023
Sponsor: AstraZeneca
Hypertension
United States
Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled StudyWithdrawn
NCT05825365Phase 2Updated Aug 14, 2023
Sponsor: AstraZeneca
Neurofibromatosis Type 1 · Plexiform Neurofibromas · Post-operative
Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy SubjectsCompleted
NCT05500820Phase 1Updated Aug 14, 2023
Sponsor: AstraZeneca
Hypertension
United States
A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.Completed
NCT04495179Phase 2Updated Aug 9, 2023
Sponsor: AstraZeneca
Progressive Metastatic Castrate-Resistant Prostate Cancer
United States, Belgium, France, South Korea, Spain
A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African AncestryCompleted
NCT05351047Phase 1Updated Aug 7, 2023
Sponsor: AstraZeneca
Healthy Volunteers
United States
AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompleted
NCT00535353Phase 1Updated Aug 4, 2023
Sponsor: NCIC Clinical Trials Group
Colorectal Cancer
Canada
Precision Medicine With Zibotentan in Microvascular AnginaCompleted
NCT04097314Phase 2Updated Aug 4, 2023
Sponsor: NHS Greater Glasgow and Clyde
Microvascular Angina
United Kingdom
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"Recruiting
NCT05919342NAUpdated Aug 4, 2023
Sponsor: NHS Greater Glasgow and Clyde
Heart Failure · Cardiovascular Diseases
United States, Canada, Denmark, Sweden, United Kingdom
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving TrastuzumabCompleted
NCT02649686Phase 1Updated Aug 4, 2023
Sponsor: Canadian Cancer Trials Group
Metastatic Breast Cancer
Canada
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompleted
NCT00265876Phase 1, Phase 2Updated Aug 4, 2023
Sponsor: NCIC Clinical Trials Group
Pancreatic Cancer
Canada
mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma MultiformeCompleted
NCT02619864Phase 1Updated Aug 4, 2023
Sponsor: Canadian Cancer Trials Group
Glioblastoma Multiforme
Canada
Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLCCompleted
NCT01783197Phase 1Updated Aug 4, 2023
Sponsor: Canadian Cancer Trials Group
Non Small Cell Lung Cancer
Canada
A Study of AZD0466 in Patients With Advanced Hematologic or Solid TumorsTerminated
NCT04214093Phase 1Updated Aug 2, 2023
Sponsor: AstraZeneca
Advanced Solid Tumors · Lymphoma · Multiple Myeloma · Hematologic Malignancies
United States
A Study of Amifostine (Ethyol) in Patients With Colorectal CancerTerminated
NCT00601198Phase 2Updated Aug 1, 2023
Sponsor: University of Cincinnati
Colorectal Cancer
United States
Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma ExacerbationTerminated
NCT04705727Phase 3Updated Jul 27, 2023
Sponsor: Centre Hospitalier Intercommunal Creteil
Asthma in Children
France
Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer PatientsCompleted
NCT01063517Phase 2Updated Jul 20, 2023
Sponsor: AstraZeneca
Gastric Cancer
South Korea
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMCompleted
NCT02981069Phase 4Updated Jul 20, 2023
Sponsor: The University of Texas Health Science Center at San Antonio
Diabetes Mellitus, Type 2
United States
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese SubjectsTerminated
NCT05794672Phase 1Updated Jul 18, 2023
Sponsor: AstraZeneca
Healthy Subjects (Indication: Asthma)
United Kingdom
A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy ParticipantsCompleted
NCT05818514EARLY_Phase 1Updated Jul 14, 2023
Sponsor: AstraZeneca
Healthy Volunteers
Sweden
A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate CancerCompleted
NCT03193060N/AUpdated Jul 14, 2023
Sponsor: AstraZeneca
Localized or Locally Advanced Prostate Cancer
China
A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male SubjectsCompleted
NCT05768360Phase 1Updated Jul 13, 2023
Sponsor: AstraZeneca
Healthy Male Subjects
Germany
A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaTerminated
NCT03970616Phase 1, Phase 2Updated Jul 12, 2023
Sponsor: AVEO Pharmaceuticals, Inc.
Hepatocellular Carcinoma
United States

Previous page Next page